PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML S Park,N Chapuis,et al. Leukemia 2008;22:1698–1706
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling Zachary A. Knight,Beatriz Gonzalez,et al. Cell 2006 May 19;125(4): 733–747
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma Qi-Wen Fan,Zachary A. Knight,et al. Cancer Cel 2006 May;9(5): 341–349
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.